22 October 2026
UK platform trial will test metformin and atomoxetine in Alzheimer’s
AD-SMART’s first stage will recruit 1,200 people, with initial results expected in 2030.
The full briefing is in the app.
22 October 2026
AD-SMART’s first stage will recruit 1,200 people, with initial results expected in 2030.
The full briefing is in the app.